BlackRock
AYTU icon

BlackRock’s AYTU BioPharma AYTU Stock Holding History

BlackRock’s Portfolio AYTU Stock Details AYTU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$49K Hold
22,793
– – ﹤0.01% 5182
2026
Q1 		$62.2K Hold
22,793
– – ﹤0.01% 5073
2025
Q4 		$59.3K Hold
22,793
– – ﹤0.01% 5015
2025
Q3 		$42.9K Hold
22,793
– – ﹤0.01% 5001
2025
Q2 		$49.7K Hold
22,793
– – ﹤0.01% 4989
2025
Q1 		$27.4K Hold
22,793
– – ﹤0.01% 5037
2024
Q4 		$38.7K Hold
22,793
– – ﹤0.01% 5002
2024
Q3 		$53.6K Hold
22,793
– – ﹤0.01% 4801
2024
Q2 		$66.6K Hold
22,793
– – ﹤0.01% 4796
2024
Q1 		$69.3K Hold
22,793
– – ﹤0.01% 4810
2023
Q4 		$64.7K Sell
22,793
-1,266
-5% -$3.49K ﹤0.01% 4914
2023
Q3 		$65K Hold
24,059
– – ﹤0.01% 4951
2023
Q2 		$38.5K Hold
24,059
– – ﹤0.01% 5112
2023
Q1 		$53.9K Sell
24,059
-1
-0% -$3 ﹤0.01% 5101
2022
Q4 		$90.9K Sell
24,060
-28
-0.1% -$105 ﹤0.01% 5069
2022
Q3 		$89K Sell
24,088
-43
-0.2% -$326 ﹤0.01% 5208
2022
Q2 		$333K Sell
24,131
-3,164
-12% -$40.5K ﹤0.01% 4890
2022
Q1 		$589K Sell
27,295
-141
-0.5% -$3.51K ﹤0.01% 4832
2021
Q4 		$741K Buy
27,436
+2,488
+10% +$108K ﹤0.01% 4755
2021
Q3 		$1.44M Buy
24,948
+776
+3% +$58.2K ﹤0.01% 4452
2021
Q2 		$2.42M Sell
24,172
-55,247
-70% -$6.48M ﹤0.01% 4179
2021
Q1 		$12.1M Buy
79,419
+64,078
+418% +$10.2M ﹤0.01% 3464
2020
Q4 		$1.84M Buy
15,341
+463
+3% +$84.3K ﹤0.01% 4072
2020
Q3 		$3.54M Buy
14,878
+9,343
+169% +$2.4M ﹤0.01% 3720
2020
Q2 		$1.57M Buy
5,535
+5,379
+3,448% +$1.63M ﹤0.01% 3895
2020
Q1 		$47K Buy
156
+43
+38% +$8.3K ﹤0.01% 4483
2019
Q4 		$22K Buy
113
+23
+26% +$4.42K ﹤0.01% 4640
2019
Q3 		$22K Sell
90
-5
-5% -$1.5K ﹤0.01% 4636
2019
Q2 		$36K Buy
+95
New +$36.2K ﹤0.01% 4619

Other funds holding AYTU

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CAM
Crown Advisors Management Larkspur, California $182M AUM 103.97% 1-Year Est. Return
DP
Diadema Partners Morristown, New Jersey $791M AUM 245.83% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

BlackRock's AYTU Position: Q2 2026 in Review

BlackRock held its AYTU BioPharma (AYTU) position steady in Q2 2026 at 22,793 shares worth $49K. The position accounts for ﹤0.01% of the portfolio, ranked #5182.

BlackRock first reported a position in AYTU in Q2 2019 and has held it in 29 quarters since. The position peaked at $12.1M in Q1 2021. 38 funds tracked by Wall St. Rank hold AYTU as of Q2 2026.

  • BlackRock held 22,793 shares of AYTU BioPharma worth $49K as of Q2 2026.
  • BlackRock left its AYTU BioPharma share count unchanged in Q2 2026.
  • AYTU BioPharma made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #5182 holding.
  • BlackRock first reported a position in AYTU BioPharma in Q2 2019 and has held it in 29 quarters since.
  • BlackRock's AYTU BioPharma position peaked at $12.1M in Q1 2021.
  • 38 funds tracked by Wall St. Rank held AYTU BioPharma as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.